Nephros to Host Analyst and Investor Virtual Event
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nephros Inc (NEPH)
Nephros Inc stock price live, this page displays NASDAQ NEPH stock exchange data. View the NEPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nephros Inc real time stock price chart below.
What Is the Nephros Inc Stock Price Today?
The Nephros Inc stock price today is 3.100.
What Is the Stock Symbol for Nephros Inc?
The stock symbol for Nephros Inc is ""NEPH.""
What Stock Exchange Does Nephros Inc Trade On?
Nephros Inc is listed and trades on the NASDAQ stock exchange.
Is Nephros Inc a Good Stock to Buy?
Determining whether Nephros Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEPH quote. (ISIN: US6406714005)
What Is the Nephros Inc Stock Price Today?
The Nephros Inc stock price today is 3.100.
What Is the Stock Symbol for Nephros Inc?
The stock symbol for Nephros Inc is ""NEPH.""
What Stock Exchange Does Nephros Inc Trade On?
Nephros Inc is listed and trades on the NASDAQ stock exchange.
Is Nephros Inc a Good Stock to Buy?
Determining whether Nephros Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEPH quote. (ISIN: US6406714005)
NASDAQ
Currency in USD
3.100
-0.140(-4.32%)
Closed·
After Hours
3.0900.000(0.00%)
·
Fair Value
An estimate of a Nephros's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.940
3.260
52 wk Range
1.364
5.000
NEPH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a Nephros's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9403.260
52 wk Range
1.3645.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NEPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nephros's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.750
Upside
+53.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Nephros Inc Company Profile
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Nephros Inc Earnings Call Summary for Q4/2024
- Q4 EPS of $0.03 beat -$0.02 forecast; revenue up 19% YoY to $3.9M; stock surged 9.72% post-announcement
- Achieved positive net income of $349,000, transitioning from $654,000 loss in Q4 2023; gross margins improved to 64%
- Expanded into new markets including airports and schools; introduced 20-inch HydroGuard Ultra Filter to boost market position
- Management aims to maintain cash-positive status, invest in R&D and marketing; expects continued growth despite challenges
- Analysts don't project full-year profitability; company faces potential supply chain issues and increased competition
Last Updated: 07/03/2025, 16:32
Read Full TranscriptCompare NEPH to Peers and Sector
Metrics to compare | NEPH | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipNEPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 41.0x | 15.0x | 12.6x | |
PEG Ratio | 0.28 | 0.00 | 0.03 | |
Price/Book | 3.5x | 1.0x | 1.4x | |
Price / LTM Sales | 2.1x | 0.6x | 1.2x | |
Upside (Analyst Target) | 46.6% | 17.3% | 17.2% | |
Fair Value Upside | Unlock | 21.4% | 6.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.750
(+53.23% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
0.05 / -0.005
Revenue / Forecast
4.88M / 3.65M
People Also Watch
FAQ
What Stock Exchange Does Nephros Trade On?
Nephros is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Nephros?
The stock symbol for Nephros is "NEPH."
What Is the Nephros Market Cap?
As of today, Nephros market cap is 32.81M.
What Is Nephros's Earnings Per Share (TTM)?
The Nephros EPS (TTM) is 0.08.
When Is the Next Nephros Earnings Date?
Nephros will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is NEPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nephros Stock Split?
Nephros has split 2 times.
How Many Employees Does Nephros Have?
Nephros has 31 employees.
What is the current trading status of Nephros (NEPH)?
As of 05 Aug 2025, Nephros (NEPH) is trading at a price of 3.10, with a previous close of 3.24. The stock has fluctuated within a day range of 2.94 to 3.26, while its 52-week range spans from 1.36 to 5.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.